Provided by Tiger Fintech (Singapore) Pte. Ltd.

Evaxion Biotech A/S

1.77
-0.0850-4.59%
Volume:39.78K
Turnover:71.00K
Market Cap:11.06M
PE:-0.09
High:1.85
Open:1.82
Low:1.70
Close:1.85
Loading ...

European Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading

MT Newswires Live
·
31 Oct 2024

Evaxion Biotech Shows Progress Amid Nasdaq Challenges

TIPRANKS
·
31 Oct 2024

Evaxion Biotech Q3 2024 GAAP EPS $(0.04) Beats $(0.31) Estimate, Sales $3.017M Beat $123.333K Estimate

Benzinga
·
31 Oct 2024

Evaxion Biotech Q3 Pretax Profit USD -2.031 Million

THOMSON REUTERS
·
31 Oct 2024

Evaxion Biotech Q3 Basic EPS USD -0.04

THOMSON REUTERS
·
31 Oct 2024

EVAX Exceeds Estimates and Confirms Partnership

Zacks Small Cap Research
·
31 Oct 2024

Evaxion Biotech A/S expected to post a loss of 31 cents a share - Earnings Preview

Reuters
·
29 Oct 2024

Evaxion Biotech to Announce Q3 Financial Results

TIPRANKS
·
28 Oct 2024

Evaxion to announce business update and third quarter 2024 financial results on October 31

GlobeNewswire
·
28 Oct 2024

European Equities Traded in the US as American Depositary Receipts Rise Friday

MT Newswires Live
·
18 Oct 2024

European Equities Traded in the US as American Depositary Receipts Nudge Lower in Wednesday Trading

MT Newswires Live
·
16 Oct 2024

European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading

MT Newswires Live
·
14 Oct 2024

European Equities Traded in the US as American Depositary Receipts Ends Week Higher in Friday Trading

MT Newswires Live
·
11 Oct 2024

OTC Markets Hosts Virtual Investor Presentation with Christian Kanstrup, CEO of Evaxion Biotech, and Brad Sorensen, Senior Analyst at Zacks SCR

Zacks Small Cap Research
·
11 Oct 2024

Evaxion Biotech’s AI Platform Shows Promising Trial Results

TIPRANKS
·
09 Oct 2024

Strong Validation of Evaxion’s AI-Immunology™ Platform in Multiple Clinical Trials

THOMSON REUTERS
·
09 Oct 2024